CRDL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cardiol Therapeutics Inc (CRDL) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock shows no significant positive catalysts, weak financial performance, and no strong trading signals. It is better to hold off on investing in this asset at the moment.
The technical indicators are mixed. The MACD histogram is positive but contracting, RSI is neutral at 63.929, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the stock price has declined by 1.40% in the regular market and 0.48% in pre-market trading, suggesting a lack of momentum. Key support and resistance levels are Pivot: 1.385, R1: 1.458, S1: 1.312, R2: 1.502, S2: 1.268.
NULL identified. There are no recent news updates, no significant insider or hedge fund activity, and no recent congress trading data.
Revenue and gross margin remain at
The stock price has also been declining recently.
In Q4 2025, Cardiol Therapeutics reported no revenue growth (0% YoY) and a decline in net income (-11.81% YoY) and EPS (-30.00% YoY). Gross margin remains at 0%. The financials indicate poor performance and lack of growth.
No analyst rating or price target changes are available for this stock.
